155 related articles for article (PubMed ID: 17287638)
1. Feasibility of treating hyperfibrinogenemia with intermittently administered batroxobin in patients with ischemic stroke/transient ischemic attack for secondary prevention.
Xu G; Liu X; Zhu W; Yin Q; Zhang R; Fan X
Blood Coagul Fibrinolysis; 2007 Mar; 18(2):193-7. PubMed ID: 17287638
[TBL] [Abstract][Full Text] [Related]
2. Danshen extracts decrease blood C reactive protein and prevent ischemic stroke recurrence: a controlled pilot study.
Xu G; Zhao W; Zhou Z; Zhang R; Zhu W; Liu X
Phytother Res; 2009 Dec; 23(12):1721-5. PubMed ID: 19449344
[TBL] [Abstract][Full Text] [Related]
3. Persistent hyperfibrinogenemia in acute ischemic stroke / transient ischemic attack (TIA).
Shenhar-Tsarfaty S; Ben Assayag E; Bova I; Shopin L; Cohen M; Berliner S; Shapira I; Bornstein NM
Thromb Haemost; 2008 Jan; 99(1):169-73. PubMed ID: 18217150
[TBL] [Abstract][Full Text] [Related]
4. Sleep disorderd breathing and recurrence of cerebrovascular events, case-fatality, and functional outcome in patients with ischemic stroke or transient ischemic attack.
Rola R; Jarosz H; Wierzbicka A; Wichniak A; Richter P; Ryglewicz D; Jernajczyk W
J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():615-21. PubMed ID: 19218688
[TBL] [Abstract][Full Text] [Related]
5. Aspirin vs anticoagulation in carotid artery dissection: a study of 298 patients.
Georgiadis D; Arnold M; von Buedingen HC; Valko P; Sarikaya H; Rousson V; Mattle HP; Bousser MG; Baumgartner RW
Neurology; 2009 May; 72(21):1810-5. PubMed ID: 19321846
[TBL] [Abstract][Full Text] [Related]
6. The Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack (PERFORM) study: baseline characteristics of the population.
Bousser MG; Amarenco P; Chamorro A; Fisher M; Ford I; Fox K; Hennerici M; Mattle HP; Rothwell PM;
Cerebrovasc Dis; 2009; 27(6):608-13. PubMed ID: 19407444
[TBL] [Abstract][Full Text] [Related]
7. [A survey on cerebral infarction/transient ischemic attack inpatients compliance with secondary stroke prevention and follow-up 90 days].
Ma RH; Wang YJ; Wang CX; Zhao XQ; Wang YL; Xu MJ; Wei M; Li Y; Zhang Z; Zhang WW; Wang L; Lin L; Li HT; Zheng T; Wang XW; Li JJ; Lü Y; Qi D
Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(37):2618-22. PubMed ID: 19080709
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up study of 72 patients with transient ischemic attacks.
Gong T; Wang X
Chin Med J (Engl); 2001 Dec; 114(12):1270-2. PubMed ID: 11793850
[TBL] [Abstract][Full Text] [Related]
9. Rationale and design of the Prevention of Cerebrovascular and Cardiovascular Events of Ischemic Origin with Terutroban in Patients with a History of Ischemic Stroke or Transient Ischemic Attack (PERFORM) Study.
Hennerici MG;
Cerebrovasc Dis; 2009; 27 Suppl 3():28-32. PubMed ID: 19439938
[TBL] [Abstract][Full Text] [Related]
10. Major vascular events after transient ischaemic attack and minor ischaemic stroke: post hoc modelling of incidence dynamics.
Atanassova PA; Chalakova NT; Dimitrov BD
Cerebrovasc Dis; 2008; 25(3):225-33. PubMed ID: 18216464
[TBL] [Abstract][Full Text] [Related]
11. In-hospital initiation of secondary prevention is associated with improved vascular outcomes at 3 months.
Rahiman A; Saver JL; Porter V; Buxton W; McNair N; Razinia T; Ovbiagele B
J Stroke Cerebrovasc Dis; 2008; 17(1):5-8. PubMed ID: 18190814
[TBL] [Abstract][Full Text] [Related]
12. [Secondary prophylaxis after ischemic stroke and transitoric ischemic attack].
Russell D; Lund C; Dahl A
Tidsskr Nor Laegeforen; 2007 May; 127(10):1379-82. PubMed ID: 17519994
[TBL] [Abstract][Full Text] [Related]
13. [Clinical efficacy of picotamide].
de Falco FA; Montariello A; Mastroroberto G; Visconti OS
Clin Ter; 1991 Jul; 138(1):21-6. PubMed ID: 1834396
[TBL] [Abstract][Full Text] [Related]
14. Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected].
Kirshner HS
Int J Clin Pract; 2007 Oct; 61(10):1739-48. PubMed ID: 17877660
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic interventions for prevention of recurrent ischemic stroke.
Kirshner HS
Am J Manag Care; 2008 Jun; 14(6 Suppl 2):S212-26. PubMed ID: 18611103
[TBL] [Abstract][Full Text] [Related]
16. Risk factor profile and management of cerebrovascular patients in the REACH Registry.
Röther J; Alberts MJ; Touzé E; Mas JL; Hill MD; Michel P; Bhatt DL; Aichner FT; Goto S; Matsumoto M; Ohman EM; Okada Y; Uchiyama S; D'Agostino R; Hirsch AT; Wilson PW; Steg PG;
Cerebrovasc Dis; 2008; 25(4):366-74. PubMed ID: 18337635
[TBL] [Abstract][Full Text] [Related]
17. Medical prevention of stroke and stroke recurrence in patients with TIA and minor stroke.
Weber R; Weimar C; Diener HC
Expert Opin Pharmacother; 2009 Aug; 10(12):1883-94. PubMed ID: 19558342
[TBL] [Abstract][Full Text] [Related]
18. Impact of abnormal diffusion-weighted imaging results on short-term outcome following transient ischemic attack.
Prabhakaran S; Chong JY; Sacco RL
Arch Neurol; 2007 Aug; 64(8):1105-9. PubMed ID: 17698700
[TBL] [Abstract][Full Text] [Related]
19. Ischemic preconditioning as induction of ischemic tolerance after transient ischemic attacks in human brain: its clinical relevance.
Schaller B
Neurosci Lett; 2005 Apr; 377(3):206-11. PubMed ID: 15755527
[TBL] [Abstract][Full Text] [Related]
20. Hyperresponsiveness of platelets in ischemic stroke.
Fateh-Moghadam S; Htun P; Tomandl B; Sander D; Stellos K; Geisler T; Langer H; Walton K; Handschu R; Garlichs C; Daniel WG; Gawaz M
Thromb Haemost; 2007 Jun; 97(6):974-8. PubMed ID: 17549300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
